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Commentary 
 
In Abdulkadir et al (1), the authors test whether a new genome-wide polygenic score 
for Tourette syndrome predicted presence and chronicity of tics in the ALSPAC 
cohort.  This new genome-wide polygenic score (GPS) for Tourette syndrome stems 
from a new genome-wide association study (GWAS) - the second and largest GWAS 
of Tourette syndrome to date. The GPS was found to predict presence but not 
chronicity of tics after correcting for multiple testing.   
 
Demonstration that the Tourette syndrome GPS derived from a clinical sample 
significantly predicts presence of tics in a community sample is a reliable form of 
biological evidence for overlap in common additive genetic influences between 
clinical and subclinical forms of tics. In the GWAS from which the GPS was created, 
participants were recruited largely from Tourette syndrome specialty clinics, which 
will mean that the sample will include severe cases of Tourette syndrome (2).  The 
ALSPAC sample, as the authors note, was recruited through the community and is a 
general population cohort; as such it will include more individuals with milder forms 
of Tourette syndrome and the full spectrum of tic severity (1). For example, the 
authors found that the Tourette syndrome GPS significantly predicted a broader 
phenotype they termed “tics all”. “Tics all” included any individuals with at least one 
positive answer to the tic screening questions between the ages of 1.5 and 13 years in 
the ALSPAC cohort. As such this is intentionally a much broader phenotype than a 
clinical diagnosis of Tourettes. The Tourette syndrome GPS predicted .78% in itself 
in an independent sample (2); in comparison it predicted .48% variance in “tics all” in 
ALSPAC (1).  
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In some further analyses, the authors reported that the Tourette syndrome GPS did not 
significantly predict other psychopathology traits in ALSPAC, namely, symptom 
severity of OCD assessed at either 7 or 13 years, and ADHD-like traits and social-
communication impairment traits both at age 7. It is interesting to consider why a 
significant prediction of the Tourette syndrome GPS with chronicity of tics and with 
other forms of psychopathology severity was not found. Within psychiatric genetics, 
significant genetic correlations between different forms of psychopathology are 
becoming pervasive in both twin and DNA-based studies. Power to predict other traits 
in GPS analyses is strongly dependent on the reliability of the GPS, which in turn 
depends on the sample size of the GWAS from which it was generated.  As such it is 
possible to imagine that, as has been found for other phenotypes (3, 4), a GPS that is 
derived from an even larger GWAS of Tourette syndrome might predict chronicity 
and other forms of psychopathology.   
 
Why is evidence for a genetic link between clinical Tourette syndrome and less severe 
tics important? One practical reason is that this type of evidence helps to inform 
practitioners, genetic counselors and families that Tourette syndrome and milder 
forms of subclinical tics are likely to run in the same families.   
 
More broadly within psychiatry and psychology, there has been a long-standing 
interest in whether psychopathology traits seen to varying degrees in the community 
are linked to clinical diagnoses.  In past work, family studies have shown that 
relatives of individuals with a clinical psychiatric disorder show elevated traits related 
to that disorder more often compared to relatives of controls. Typical family studies 
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cannot however disentangle whether such familiality is due to the family environment 
or shared genetic influences among relatives.  Twin studies have shown that the 
heritability of traits within psychopathology does not change across the severity 
continuum and there appears to be a genetic link between severe psychopathology 
traits and those in the normal range see e.g., (4).  Finally, reviews of the literature 
have noted that the same environmental risk factors show associations with both 
disorders and less severe manifestations of symptoms  - see, for example, for 
schizophrenia and psychotic-like experiences (5).     
 
The results reported in this journal’s new paper (1) provide another source of 
evidence, at the measured genotype level, for overlap in causal influences between 
milder and more severe forms of psychopathology.  To put it in context, Table 1 
summarises what has been reported for four psychiatric disorders from recent GWAS 
studies.  The “percent variance predicted in disorder itself by GPS” column shows the 
amount of variance in liability that the GPS predicts in the same disorder in an 
independent sample. The “percent variance predicted in related trait by disorder GPS” 
shows the percent variance in a related trait that the disorder GPS predicts in an 
independent community sample.  If we divide the second value by the first, the 
relative predictive power of the GPS to predict a related trait compared to predicting 
the disorder itself is demonstrated. For these four psychiatric disorders, GPS 
associated with each disorder currently predicts 10-20% variance in the related trait 
compared to what it predicts in itself (Table 1) (4). Nevertheless, for all these four 
disorders, and now also for Tourette syndrome, we appear to have evidence of some 
overlap in common additive genetic influences between milder subclinical and more 
severe clinically-recognised forms of psychopathology.   
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Why do disorder GPS not predict as much variance in traits as they do in themselves 
(i.e. the same disorder) in an independent sample? One possible reason is disorders 
tend to include more than simply scoring high on trait scales. Disorder diagnoses 
often require specific combinations of multiple symptoms, as well as criteria relating 
to impairment in functioning brought about by the symptoms.  Traits are often 
measured at a single age whereas diagnoses depend on symptoms having been 
persistent over a period of time before diagnoses are made.  
 
Abdulkadir et al’s new paper in Biological Psychiatry expands our understanding of 
the links between subclinical and clinical manifestations of psychopathology, and 
makes a valuable new contribution to the growing field of the molecular genetics of 
Tourette’s syndrome.   
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Table 1. Effect sizes of genome-wide polygenic score predictions for four psychiatric 
disorders and their related dimensional traits  
Disorder 
genome-wide 
polygenic score 
Related trait Variance predicted in 
disorder itself by 
disorder GPS (%) 
(A) 
Variance predicted in 
related trait by 
disorder GPS (%) (B) 
B/A 
Autism Autistic traits 1.13% (6) .1% (6) 9% 
Schizophrenia Negative 
symptom traits 
7% (3) .7% (7) 10% 
Depression Depressive 
traits 
.72% (8) .11% (9)  15% 
ADHD ADHD traits 3.71% (10) .8% (10) 22% 
 
 
